Stock Groups

Act now to curb Omicron’s spread, WHO’s Tedros tells world -Breaking

[ad_1]

© Reuters. FILE PHOTO Tedros Adhanom Gobreyesus, chief of World Health Organization, attends an event to inaugurate a multiyear partnership between Qatar and FIFA Football World Cup 2022.

By Stephanie Nebehay

GENEVA (Reuters), -Governments should reevaluate national response to COVID-19, and accelerate vaccination programs to combat Omicron. However, it’s too soon to know how effective existing vaccines will be against this new variant of the disease, according to the World Health Organization on Wednesday.

Global spread of the variant suggests that it may have an impact on COVID-19’s pandemic. It is time to stop it before Omicron patient are more hospitalised, Tedros Adhanom Gobreyesus, WHO director general, said.

He said that he called on countries to improve surveillance, testing, and sequencing. “… Complacency will lead to the loss of lives.

Mike Ryan, WHO Emergency Director, said the variant seems to have spread more readily and that efforts should be intensified to stop transmission.

BioNTech was noted by the WHO as an early sign of evidence. Pfizer (NYSE:) The effectiveness of their Omicron vaccine.

According to the U.S.-based companies, a combination of three shots of COVID-19 vaccine and two other doses of COVID-19 vaccine were able to neutralise Omicron’s new variant.

Chief scientist at WHO warned against jumping to any conclusions about the results of the WHO test.

It is too early to assume that a decrease in neutralizing activity will result in significant decreases in vaccine effectiveness. Swaminathan explained that this is not possible because our immune system is complex.

We need to coordinate our research efforts and not just jump from one study to the next.

Ana Maria Henao–Restrepo is the WHO’s head of research-and-development unit. She stated that Monday’s closed-door meeting had discussed variability in early Omicron vaccine results.

According to her, “Neutralizing antibodies are an important piece.

Although the WHO stated that it will publish its position on booster doses in a matter of days, with low vaccination rates across much of the developing world and a lack of vaccine coverage, primary shots remain WHO’s priority.

Swaminathan asserted that “Wholesale boosters do not solve the problem.”

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of the potential risks and financial costs involved in trading the financial market. It is the most risky form of investment.

[ad_2]